Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 10 2019
Historique:
received: 11 09 2018
accepted: 27 12 2018
pubmed: 1 1 2019
medline: 15 9 2020
entrez: 1 1 2019
Statut: ppublish

Résumé

The known relationship between the gestational age at maternal primary infection an the outcome of congenital CMV is based on small, retrospective studies conducted between 1980 and 2011. They reported that 32% and 15% of cases had sequelae following a maternal primary infection in the first and second or the third trimester, respectively. We aimed to revisit this relationship prospectively between 2011 and 2017, using accurate virological tools. We collected data on women with a primary infection and an infected child aged at least 1 year at the time of analysis. An accurate determination of the timing of the primary infection was based upon serial measurements of immunoglobulin (Ig) M and IgG and on IgG avidity in sera collected at each trimester. The case outcome was assessed according to a structured follow-up between birth and 48 months. We included 255 women and their 260 fetuses/neonates. The dating of the maternal infection was prospective in 86% of cases and retrospective in 14%. At a median follow-up of 24 months, the proportion of sensorineural hearing loss and/or neurologic sequelae were 32.4% (95% confidence interval [CI] 23.72-42.09) after a maternal primary infection in the first trimester, 0 (95% CI 0-6.49) after an infection in the second trimester, and 0 (95% CI 0-11.95) after an infection in the third trimester (P < .0001). These results suggest that a cytomegalovirus infection can be severe only when the virus hits the fetus in the embryonic or early fetal period. Recent guidelines recommend auditory follow-ups for at least 5 years for all infected children. This raises parental anxiety and generates significant costs. We suggest that auditory and specialized neurologic follow-ups may be recommended only in cases of a maternal infection in the first trimester.

Sections du résumé

BACKGROUND
The known relationship between the gestational age at maternal primary infection an the outcome of congenital CMV is based on small, retrospective studies conducted between 1980 and 2011. They reported that 32% and 15% of cases had sequelae following a maternal primary infection in the first and second or the third trimester, respectively. We aimed to revisit this relationship prospectively between 2011 and 2017, using accurate virological tools.
METHODS
We collected data on women with a primary infection and an infected child aged at least 1 year at the time of analysis. An accurate determination of the timing of the primary infection was based upon serial measurements of immunoglobulin (Ig) M and IgG and on IgG avidity in sera collected at each trimester. The case outcome was assessed according to a structured follow-up between birth and 48 months.
RESULTS
We included 255 women and their 260 fetuses/neonates. The dating of the maternal infection was prospective in 86% of cases and retrospective in 14%. At a median follow-up of 24 months, the proportion of sensorineural hearing loss and/or neurologic sequelae were 32.4% (95% confidence interval [CI] 23.72-42.09) after a maternal primary infection in the first trimester, 0 (95% CI 0-6.49) after an infection in the second trimester, and 0 (95% CI 0-11.95) after an infection in the third trimester (P < .0001).
CONCLUSIONS
These results suggest that a cytomegalovirus infection can be severe only when the virus hits the fetus in the embryonic or early fetal period. Recent guidelines recommend auditory follow-ups for at least 5 years for all infected children. This raises parental anxiety and generates significant costs. We suggest that auditory and specialized neurologic follow-ups may be recommended only in cases of a maternal infection in the first trimester.

Identifiants

pubmed: 30596974
pii: 5267872
doi: 10.1093/cid/ciy1128
doi:

Banques de données

ClinicalTrials.gov
['NCT01651585', 'NCT01923636']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1526-1532

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Valentine Faure-Bardon (V)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Maternity, Hospital Necker-E.M, Paris, France.

Jean-François Magny (JF)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Neonatal Intensive Care Unit, Hospital Necker-E.M, France.

Marine Parodi (M)

Otology Department, Assistance Publique de Paris, Hospital Necker-E.M, France.

Sophie Couderc (S)

Maternity, Hospital Intercommunal Poissy-Saint Germain, Marseille, France.

Patricia Garcia (P)

Neonatology and Intensive Care Department, Assistance Publique de Marseille, Hospital La Conception, Marseille, France.

Anne-Marie Maillotte (AM)

Neonatal Intensive Care Unit, Centre Hospitalier Universitaire Nice, Hospital L'Archet, Marseille, France.

Melinda Benard (M)

Department of Neonatalogy, Toulouse University Hospital, Saint-Etienne, France.

Didier Pinquier (D)

Department of Neonatalogy, Rouen University Hospital, Saint-Etienne, France.

Dominique Astruc (D)

Department of Neonatalogy, Strasbourg University Hospital, Saint-Etienne, France.

Hugues Patural (H)

Neonatal Intensive Care Unit, University Hospital, Saint-Etienne, France.

Patrick Pladys (P)

Pediatric Department, Neonatology, Centre Hospitalier Universitaire Rennes and Centre d'Investigation Clinique, France.

Sophie Parat (S)

Maternity, Assistance Publique Hopitaux de Paris (AP-HP), Hospital Cochin, France.

Bernard Guillois (B)

Department of Neonatalogy, Centre Hospitalier Universitaire de Caen, France.
Medical School, Université Caen Normandie, France.

Armelle Garenne (A)

Brest, Neonatal and Pediatric Intensive Care Unit, Centre Hospitalier Régional Universitaire, France.

Laurence Bussières (L)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Clinical Research Unit, AP-HP, Hospital Necker-E.M., France.

Tiffany Guilleminot (T)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Virology Laboratory, Reference Laboratory for Cytomegalovirus Infections, AP-HP, Hospital Necker-E.M., France.

Julien Stirnemann (J)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Maternity, Hospital Necker-E.M, Paris, France.

Idir Ghout (I)

Unité de Recherche Clinique et Département de Santé Publique, AP-HP, Hôpital Ambroise Paré, Boulogne, France.
University Versaille-Saint-Quentin, Unité Mixte de recherche S, Université Versailles St-Quentin-en-Yvelines, Montigny, France.

Yves Ville (Y)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Maternity, Hospital Necker-E.M, Paris, France.

Marianne Leruez-Ville (M)

Equipe d'Accueil, Paris Descartes University, Sorbonne Paris CitéArchet, France.
Virology Laboratory, Reference Laboratory for Cytomegalovirus Infections, AP-HP, Hospital Necker-E.M., France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH